Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protoporphyrin IX (PpIX) is a naturally occurring, potent endogenous photosensitizer and a precursor in the heme biosynthetic pathway. In the context of Photodynamic Therapy (PDT), the administration of 5-aminolevulinic acid (ALA) or its derivatives leads to the selective accumulation of PpIX within metabolically active cells, particularly malignant and premalignant cells, due to altered enzyme activities in the heme cycle (Agostinis et al., 2011, CA: A Cancer Journal for Clinicians). When these cells are exposed to specific wavelengths of light (typically blue or red), PpIX absorbs the energy and facilitates the production of Reactive Oxygen Species (ROS), primarily singlet oxygen (National Cancer Institute). These ROS are highly reactive and short-lived, causing localized oxidative destruction of critical cellular biomolecules such as phospholipids in the plasma and mitochondrial membranes, functional proteins, and DNA (Kennedy et al., 1990, Journal of Photochemistry and Photobiology). This targeted damage disrupts cellular integrity and signaling, leading to cell death via apoptosis, necrosis, or autophagy, making it a highly effective treatment for localized cancers and dermatological conditions like actinic keratosis (StatPearls, 2023). The therapeutic window is defined by the selective accumulation of PpIX in diseased tissue and the precise application of light, minimizing damage to surrounding healthy structures.
Photoactivation of Protoporphyrin IX (PpIX) by specific wavelengths of light induces a Type II photochemical reaction, transferring energy to molecular oxygen to generate singlet oxygen and other reactive oxygen species (ROS). These ROS cause irreversible oxidative damage to nearby cellular biomolecules, including membrane lipids (lipid peroxidation), structural and enzymatic proteins, and nucleic acids, ultimately triggering programmed or necrotic cell death.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular biomolecules (Proteins, Lipids, and DNA) (PpIX-targets).